A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

NCT00000795 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy

NCT02028403 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)

NCT04799353 ·Status: COMPLETED ·Phase: PHASE1

An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients.

NCT03517631 ·Status: UNKNOWN ·Phase: PHASE1

Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)

NCT01423825 ·Status: COMPLETED ·Phase: PHASE1

3BNC117-LS First-in-Human Phase 1 Study

NCT03254277 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults

NCT01799954 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants

NCT05217641 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3

NCT00000756 ·Status: COMPLETED ·Phase: PHASE1

3BNC117 and 10-1074 in HIV Uninfected Adults

NCT02824536 ·Status: COMPLETED ·Phase: PHASE1

Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART

NCT05144386 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult Participants

NCT03934541 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults

NCT02915016 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2)

NCT01152255 ·Status: TERMINATED ·Phase: PHASE1

Safety Study of IL-7 in HIV-infected Patients (Inspire)

NCT00477321 ·Status: COMPLETED ·Phase: PHASE1

Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection

NCT00001386 ·Status: COMPLETED ·Phase: PHASE1

3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

NCT05245292 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIV

NCT06557785 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS

NCT00963235 ·Status: COMPLETED ·Phase: PHASE3

Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults

NCT04173819 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults

NCT00051454 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects

NCT00623259 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)

NCT00000775 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants

NCT03735849 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers

NCT02038842 ·Status: COMPLETED ·Phase: PHASE1/PHASE2